The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors

Abstract

Unconditioned rewarding stimuli evoke phasic increases in dopamine concentration in the nucleus accumbens (NAc) while discrete aversive stimuli elicit pauses in dopamine neuron firing and reductions in NAc dopamine concentration. The unconditioned effects of more prolonged aversive states on dopamine release dynamics are not well understood and are investigated here using the malaise-inducing agent lithium chloride (LiCl). We used fast-scan cyclic voltammetry to measure phasic increases in NAc dopamine resulting from electrical stimulation of dopamine cell bodies in the ventral tegmental area (VTA). Systemic LiCl injection reduced electrically evoked dopamine release in the NAc of both anesthetized and awake rats. As some behavioral effects of LiCl appear to be mediated through glucagon-like peptide-1 receptor (GLP-1R) activation, we hypothesized that the suppression of phasic dopamine by LiCl is GLP-1R dependent. Indeed, peripheral pretreatment with the GLP-1R antagonist exendin-9 (Ex-9) potently attenuated the LiCl-induced suppression of dopamine. Pretreatment with Ex-9 did not, however, affect the suppression of phasic dopamine release by the kappa-opioid receptor agonist, salvinorin A, supporting a selective effect of GLP-1R stimulation in LiCl-induced dopamine suppression. By delivering Ex-9 to either the lateral or fourth ventricle, we highlight a population of central GLP-1 receptors rostral to the hindbrain that are involved in the LiClmediated suppression of NAc dopamine release. Neuropsychopharmacology (2016) 41, 906-915;

Central amygdala circuits modulate food consumption through a positive valence mechanism

“…We next asked whether activation of CeA Htr2a neurons could increase consumption under anorexigenic conditions where motivation to find and consume food is low 21–24 . Indeed, chemogenetic activation of CeA Htr2a neurons in fasted mice decreased the appetite suppressant effects of lithium chloride (LiCl) and lipopolysaccharide (LPS) that mimic toxic foods and bacterial infections respectively 25 (Fig.…”

Nicotine pre-treatment reduces sensitivity to the interoceptive stimulus effects of commonly abused drugs as assessed with taste conditioning paradigms

“…Furthermore, this differentiation demonstrates that nicotine is not simply interfering with taste processes or the ability to learn CTR as rats were capable of acquiring and expressing functional CTAs when conditioned with LiCl and showed revaluation to a high dose of morphine. It is possible that this dissociation is driven by the common ability for these drugs of abuse to heighten dopaminergic activity (Hunt et al, 1985), a property not shared by LiCl, a compound with no known abuse potential in humans; LiCl appears to inhibit dopamine release (Fortin et al, 2016). …”

The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania

“…Lithium treatment can suppress phasic dopamine release (Fortin et al, 2015), which could be a result from lithium chloride-induced cation leakage from the DAT (Borre et al, 2014). It is perhaps this mechanism of lithium-induced leakage that results in the long-term increase in DAT levels.…”